Cite
Maijaroen S, Klaynongsruang S, Reabroi S, et al. Proteomic profiling reveals antitumor effects of RT2 peptide on a human colon carcinoma xenograft mouse model. Eur J Pharmacol. 2022;174753doi: 10.1016/j.ejphar.2022.174753.
Maijaroen, S., Klaynongsruang, S., Reabroi, S., Chairoungdua, A., Roytrakul, S., Daduang, J., Taemaitree, L., & Jangpromma, N. (2022). Proteomic profiling reveals antitumor effects of RT2 peptide on a human colon carcinoma xenograft mouse model. European journal of pharmacology, 174753. https://doi.org/10.1016/j.ejphar.2022.174753
Maijaroen, Surachai, et al. "Proteomic profiling reveals antitumor effects of RT2 peptide on a human colon carcinoma xenograft mouse model." European journal of pharmacology vol. (2022): 174753. doi: https://doi.org/10.1016/j.ejphar.2022.174753
Maijaroen S, Klaynongsruang S, Reabroi S, Chairoungdua A, Roytrakul S, Daduang J, Taemaitree L, Jangpromma N. Proteomic profiling reveals antitumor effects of RT2 peptide on a human colon carcinoma xenograft mouse model. Eur J Pharmacol. 2022 Jan 12;174753. doi: 10.1016/j.ejphar.2022.174753. Epub 2022 Jan 12. PMID: 35032485.
Copy
Download .nbib